pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

7,829 catalysts · 3,189 8k filing · 1,368 grant · 1,000 device adverse event · 615 approval · 582 earnings · 476 device 510k

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-10: 0 catalysts2026-08-11: 0 catalysts2026-08-12: 0 catalysts2026-08-13: 19 catalysts2026-08-14: 4 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 3 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
from 2026-02-24×clear all
type
  • 8k filing3,189
  • grant1,368
  • device adverse event1,000
  • approval615
  • earnings582
  • device 510k476
device pma
297
  • phase 2 completion172
  • drug shortage133
  • recall121
  • therapy area
    • Oncology148
    • Infectious Disease46
    • Cardiology37
    • Immunology35
    • Dermatology31
    • Pulmonology22
    • Women's Health19
    • Ophthalmology16
    • Pain15

    Week of Feb 23, 2026

    50
    ›Feb 25, 2026approval169d agoSAXENDA (LIRAGLUTIDE) — FDA approvalNovo Nordisk Inc

    Sponsor: NOVO. Form: SOLUTION. Route: SUBCUTANEOUS

    full page →fda approvals ↗
    ›Feb 25, 2026approval169d agoZIOPTAN (TAFLUPROST) — FDA approvaltafluprost

    Sponsor: THEA PHARMA. Form: SOLUTION/DROPS. Route: OPHTHALMIC

    full page →tafluprost →fda approvals ↗
    ›Feb 25, 2026approval169d agoZEPBOUND (TIRZEPATIDE) — FDA approvalZEPBOUND

    Sponsor: ELI LILLY AND CO. Form: SOLUTION. Route: SUBCUTANEOUS

    full page →ZEPBOUND →fda approvals ↗
    ›Feb 25, 2026approval169d agoENTYVIO (VEDOLIZUMAB) — FDA approvalTakeda Pharmaceuticals USA Inc

    Sponsor: TAKEDA PHARMS USA. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Feb 25, 2026approval169d agoDEXMEDETOMIDINE HYDROCHLORIDE — FDA approvalBioXcel Therapeutics, Inc.

    Sponsor: DR REDDYS. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Feb 25, 2026approval169d agoHYDROCORTISONE — FDA approvalET-800

    Sponsor: APPCO. Form: TABLET. Route: ORAL

    full page →ET-800 →fda approvals ↗
    ›Feb 25, 2026approval169d agoCETIRIZINE HYDROCHLORIDE — FDA approvalCETIRIZINE HYDROCHLORIDE

    Sponsor: RUBICON RESEARCH. Form: SOLUTION. Route: ORAL

    full page →CETIRIZINE HYDROCHLORIDE →fda approvals ↗
    ›Feb 25, 2026approval169d agoBUPROPION HYDROCHLORIDE — FDA approvalSenores Pharmaceuticals Inc

    Sponsor: SENORES PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Feb 25, 2026approval169d agoONDANSETRON HYDROCHLORIDE — FDA approvalondansetron hydrochloride CR

    Sponsor: DR REDDYS LABS LTD. Form: TABLET. Route: ORAL

    full page →ondansetron hydrochloride CR →fda approvals ↗
    ›Feb 25, 2026approval169d agoEVEROLIMUS — FDA approvalPostsurgical Therapeutics Inc

    Sponsor: EUGIA PHARMA. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Feb 25, 2026approval169d agoANASTROZOLE — FDA approvalStason Pharmaceuticals Inc

    Sponsor: BEIJING YILING. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Feb 25, 2026approval169d agoONDANSETRON HYDROCHLORIDE — FDA approvalondansetron hydrochloride CR

    Sponsor: RISING. Form: TABLET. Route: ORAL

    full page →ondansetron hydrochloride CR →fda approvals ↗
    ›Feb 25, 2026approval169d agoENTYVIO (VEDOLIZUMAB) — FDA approvalTakeda Pharmaceuticals USA Inc

    Sponsor: TAKEDA PHARMS USA. Form: INJECTABLE. Route: INTRAVENOUS

    full page →fda approvals ↗
    ›Feb 25, 2026approval169d agoJUXTAPID (LOMITAPIDE MESYLATE) — FDA approvalChiesi USA Inc

    Sponsor: CHIESI. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Feb 25, 2026approval169d agoDESMODA (DESMOPRESSIN ACETATE) — FDA approvaldesmopressin acetate

    Sponsor: ETON. Form: SOLUTION. Route: ORAL

    full page →desmopressin acetate →fda approvals ↗
    ›Feb 25, 2026approval169d agoLAMOTRIGINE — FDA approvalLAMOTRIGINE

    Sponsor: ALEMBIC. Form: TABLET, ORALLY DISINTEGRATING. Route: ORAL

    full page →LAMOTRIGINE →fda approvals ↗
    ›Feb 25, 2026device 510k169d agoBecton, Dickinson and Company (BD) — BD Surgiphor™ Antimicrobial Irrigation System (910110) (510k cleared)BECTON DICKINSON & CO

    Product code: FQH. Advisory committee: General Hospital. Type: Special

    full page →fda device 510k ↗
    ›Feb 25, 2026device 510k169d agoSpinal Elements, Inc. — Ventana™ A Anterior Lumbar Interbody System (510k cleared)

    Product code: OVD. Advisory committee: Orthopedic. Type: Traditional

    full page →fda device 510k ↗
    ›Feb 25, 2026device 510k169d agoZhejiang Yikang Medical Technology Co., Ltd. — Electric wheelchair (510k cleared)Zhejiang Xinkanghe Biomedical Technology Co Ltd

    Product code: ITI. Advisory committee: Physical Medicine. Type: Traditional

    full page →fda device 510k ↗
    ›Feb 25, 2026device 510k169d agoMedline Industries, LP — Konig Bell Circumcision Clamp (510k cleared)

    Product code: HFX. Advisory committee: Obstetrics/Gynecology. Type: Traditional

    full page →fda device 510k ↗
    ›Feb 25, 2026device 510k169d agoGrindguard, Inc. — Remi Impression Material (510k cleared)

    Product code: SHI. Advisory committee: Dental. Type: Traditional

    full page →fda device 510k ↗
    ›Feb 25, 2026device 510k169d agoMako Surgical Corp. — Mako Total Knee Application (510k cleared)

    Product code: OLO. Advisory committee: Neurology. Type: Special

    full page →fda device 510k ↗
    ›Feb 25, 2026device 510k169d agoMighty Oak Medical — FIREFLY® Pedicle Screw Navigation Guide (510k cleared)

    Product code: PQC. Advisory committee: Orthopedic. Type: Traditional

    full page →fda device 510k ↗
    ›Feb 25, 2026device pma169d agoNovocure, GmbH — Optune Gio® (PMA supplement)NovoCure Ltd

    Supplement type: 30-Day Notice. Product code: NZK. Advisory committee: NE. Decision: OK30

    full page →fda device pma ↗
    ›Feb 25, 2026device pma169d agoBoston Scientific Corporation — Axonics Sacral Neuromodulation System (PMA supplement)BOSTON SCIENTIFIC CORP

    Supplement type: 30-Day Notice. Product code: EZW. Advisory committee: GU. Decision: OK30

    full page →fda device pma ↗
    ›Feb 25, 2026device pma169d agoBoston Scientific Corporation — Axonics Sacral Neuromodulation System (PMA supplement)BOSTON SCIENTIFIC CORP

    Supplement type: 30-Day Notice. Product code: QON. Advisory committee: GU. Decision: OK30

    full page →fda device pma ↗
    ›Feb 25, 2026device pma169d agoABBOTT MEDICAL — TriClip™ G5 Delivery System (TCDS0801-NT, TCDS0801-NTW, TCDS0801-XT, TCDS0801-XTW) (PMA supplement)

    Supplement type: Real-Time Process. Product code: NPS. Advisory committee: CV. Decision: APPR

    full page →fda device pma ↗
    ›Feb 25, 2026device pma169d agoIntegra Lifesciences Corp. — INTEGRA ® Dermal Regeneration Template; Integra® Meshed Dermal Regeneration Template; Integra® Omnigraft Dermal Regenera (PMA supplement)INTEGRA LIFESCIENCES HOLDINGS CORP

    Supplement type: 30-Day Notice. Product code: MGR. Advisory committee: SU. Decision: OK30

    full page →fda device pma ↗
    ›Feb 25, 2026device pma169d agoABBOTT MEDICAL — MitraClip™ G5 Delivery System (CDS0801-NT, CDS0801-NTW, CDS0801-XT, CDS0801-XTW) (PMA supplement)

    Supplement type: Real-Time Process. Product code: NKM. Advisory committee: CV. Decision: APPR

    full page →fda device pma ↗
    ›Feb 25, 2026device pma169d agoNovocure, GmbH — Optune Lua® (PMA supplement)NovoCure Ltd

    Supplement type: 30-Day Notice. Product code: SDA. Advisory committee: AN. Decision: OK30

    full page →fda device pma ↗
    ›Feb 25, 2026device pma169d agoBoston Scientific Corp — AMS 800™ Artificial Urinary Sphincter (AUS) (PMA supplement)BOSTON SCIENTIFIC CORP

    Supplement type: 30-Day Notice. Product code: EZY. Advisory committee: GU. Decision: OK30

    full page →fda device pma ↗
    ›Feb 25, 2026device recall169d agoSynthes (USA) Products LLC device recall (Cls II)

    2.4 VOLT TAP LOCKING SCREW TAP TO 90MM. Part Number: 03.424.124-US. — Reason: A full lot swap between VOLT Locking Screw Tap 03.424.124 lot 68900P9 and Cortical Screw Tap 03.424.126 lot 68982P8, resulting in the bones taps having an incorrect thread. — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 25, 2026device recall169d agoOlympus Corporation of the Americas device recall (Cls II)

    Brand Name: Olympus PKS Cutting Forceps, 5mm 33cm Product Name: PKS Cutting Forceps Model/Catalog Number: 3005PK Product Description: The PKS Cutting Forceps are intended to be passed through a 5mm cannula. Coagulation is achieved using electrosurgical energy under visualization. The device is intended to be used with the PKS electrical generator. — Reason: Olympus identified that the Cutting Forceps contain components for which the supplier did not adequately validate the welding process. Defective welds can result in the Cutting Forceps' jaw breaking during clinical use. — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 25, 2026device recall169d agoOlympus Corporation of the Americas device recall (Cls II)

    Brand Name: Olympus PKS Cutting Forceps w/Cord, 5mm 24cm Product Name: PKS Cutting Forceps Model/Catalog Number: 920000PK Product Description: The PKS Cutting Forceps are intended to be passed through a 5mm cannula. Coagulation is achieved using electrosurgical energy under visualization. The device is intended to be used with the PKS electrical generator. — Reason: Olympus identified that the Cutting Forceps contain components for which the supplier did not adequately validate the welding process. Defective welds can result in the Cutting Forceps' jaw breaking during clinical use. — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 25, 2026device recall169d agoOlympus Corporation of the Americas device recall (Cls II)

    Brand Name: Olympus PK Cutting Forceps, 5mm 33cm Product Name: PK Cutting Forceps Model/Catalog Number: PK-CF0533 Product Description: An assembly of devices intended to generate and apply radio-frequency (RF) alternating current to soft tissues for cutting and coagulation during an endoscopic or open surgical procedure. — Reason: Olympus identified that the Cutting Forceps contain components for which the supplier did not adequately validate the welding process. Defective welds can result in the Cutting Forceps' jaw breaking during clinical use. — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 25, 2026device recall169d agoOlympus Corporation of the Americas device recall (Cls II)

    Brand Name: Olympus Everest Bipolar Cutting Forceps, 5 mm 33 cm Product Name: Everest Bipolar Cutting Forceps Model/Catalog Number: 3005 Product Description: The OLYMPUS Everest Bipolar Cutting Forceps are intended to be passed through a 5 mm cannula. Coagulation is achieved using electrosurgical energy under visualization. The device is intended to be used with the bipolar outputs of compatible generators. — Reason: Olympus identified that the Cutting Forceps contain components for which the supplier did not adequately validate the welding process. Defective welds can result in the Cutting Forceps' jaw breaking during clinical use. — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 25, 2026device recall169d agoOlympus Corporation of the Americas device recall (Cls II)

    Brand Name: Olympus Everest Bipolar Cutting Forceps w/Cord, 5mm 33 cm Product Name: Everest Bipolar Cutting Forceps Model/Catalog Number: 3006 Product Description: The OLYMPUS Everest Bipolar Cutting Forceps are intended to be passed through a 5 mm cannula. Coagulation is achieved using electrosurgical energy under visualization. The device is intended to be used with the bipolar outputs of compatible generators. — Reason: Olympus identified that the Cutting Forceps contain components for which the supplier did not adequately validate the welding process. Defective welds can result in the Cutting Forceps' jaw breaking during clinical use. — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 25, 2026device recall169d agoOlympus Corporation of the Americas device recall (Cls II)

    Brand Name: Olympus PKS Cutting Forceps, 5mm 33cm Product Name: PKS Cutting Forceps Model/Catalog Number: 920005PK Product Description: The PKS Cutting Forceps are intended to be passed through a 5mm cannula. Coagulation is achieved using electrosurgical energy under visualization. The device is intended to be used with the PKS electrical generator. — Reason: Olympus identified that the Cutting Forceps contain components for which the supplier did not adequately validate the welding process. Defective welds can result in the Cutting Forceps' jaw breaking during clinical use. — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 25, 2026device recall169d agoOlympus Corporation of the Americas device recall (Cls II)

    Brand Name: Olympus HALO PKS Cutting Forceps, 5mm 33cm Product Name: HALO PKS Cutting Forceps Model/Catalog Number: HACF0533 Product Description: The HALO PKS Cutting Forceps are intended to be passed through a 5 mm laparoscopic cannula. Coagulation is achieved using electrosurgical energy under laparoscopic visualization. The device is intended to be used with the Gyrus ACMI G400 Workstation only. — Reason: Olympus identified that the Cutting Forceps contain components for which the supplier did not adequately validate the welding process. Defective welds can result in the Cutting Forceps' jaw breaking during clinical use. — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 25, 2026device recall169d agoSynthes (USA) Products LLC device recall (Cls II)

    2.4 VOLT(TM) TAP CORTEX SCREW TO 90MM. Part Number: 03.424.126-US. — Reason: A full lot swap between VOLT Locking Screw Tap 03.424.124 lot 68900P9 and Cortical Screw Tap 03.424.126 lot 68982P8, resulting in the bones taps having an incorrect thread. — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 25, 2026grant169d agoHENRY FORD HEALTH + MICHIGAN STATE UNIVERSITY HEALTH SCIENCES — Advancing Cardiovascular Health Among Adolescents with Intellectual Disabilit...

    NR grant. $169,189. PI: Patricia Marie West

    full page →nih reporter ↗
    ›Feb 25, 2026grant169d agoUNIVERSITY OF COLORADO DENVER — Understanding the contributions of MAIT cells in colitisUniversity of Colorado Denver

    AI grant. $429,000. PI: Li Yen Loh

    full page →nih reporter ↗
    ›Feb 25, 2026grant169d agoKEYSTONE SYMPOSIA — B and T Cell Collaboration in Lymphoid and Nonlymphoid Microenvironments

    AI grant. $14,000. PI: TERRY L. SHEPPARD

    full page →nih reporter ↗
    ›Feb 25, 2026grant169d agoKEYSTONE SYMPOSIA — B Cells and Plasma Cells: Fundamental and Translational Biology

    AI grant. $15,500. PI: TERRY L. SHEPPARD

    full page →nih reporter ↗
    ›Feb 25, 2026grant169d agoFLORIDA STATE UNIVERSITY — Multi-level factors influencing maternal and infant health outcomes

    HD grant. $540,915. PI: Patricia Ann Homan

    full page →nih reporter ↗
    ›Feb 25, 2026grant169d agoMAYO CLINIC JACKSONVILLE — Role of meningeal lymphatic drainage in CSF1R-related leukoencephalopathyMayo Clinic

    NS grant. $50,114. PI: Guadalupe Sanchez

    full page →nih reporter ↗
    ›Feb 26, 2026approval168d agoXeomin (incobotulinumtoxinA) — FDA approvalMerz Pharmaceuticals LLC

    Sponsor: MERZ PHARMS. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Feb 26, 2026approval168d agoDAPSONE — FDA approvalDAPSONE

    Sponsor: ZYDUS LIFESCIENCES. Form: TABLET. Route: ORAL

    full page →DAPSONE →fda approvals ↗
    ›Feb 26, 2026approval168d agoJASCAYD (NERANDOMILAST) — FDA approvalnerandomilast

    Sponsor: BOEHRINGER INGELHEIM. Form: TABLET. Route: ORAL

    full page →nerandomilast →fda approvals ↗
    ›Feb 26, 2026approval168d agoVYVGART HYTRULO (EFGARTIGIMOD ALFA AND HYALURONIDASE-QVFC) — FDA approvalARGENX SE

    Sponsor: ARGENX BV. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ← prev
    page 2 of 157
    next →
    $NVCR20.05+28.74%
    $BTAI0.9215-10.53%
    $BDX183.58+1.20%
    $NVCR20.05+28.74%
    $IART17.38+0.06%
    $BSX51.42+0.45%
    $ETON41.58-1.12%
    $RDY12.39-0.48%
    $BSX51.42+0.45%
    $LLY1220.28+0.43%
    $BSX51.42+0.45%
    $ARGX876.00+1.30%